HYDERABAD: Aurobindo Pharma has announced the completion of a deal of acquisition of intellectual property and marketing authorisation with TAD Italy, a registered generic company in Italy. This would give Aurobindo an access to more than 70 ready-to-market products which would accelerate the company’s entry into Italian markets. — Special Correspondent